Key result
Higher LVMI and lower e' linked to increased risk of major cardiovascular events in women.
Why the study?
GLS may not predict cardiovascular outcomes as effectively in women, necessitating identification of echocardiographic predictors of cardiovascular morbidity and mortality in women from the general population.
Do echocardiographic parameters such as LVMI and e' predict cardiovascular morbidity and mortality in women from the general population?
Cohort (n=1,245)
Do echocardiographic parameters such as LVMI and e' predict cardiovascular morbidity and mortality in women from the general population?
In women from the general population, left ventricular mass index and diastolic dysfunction (e'), but not global longitudinal strain, are independent predictors of adverse cardiovascular outcomes.
Answers are grounded in this paper and cite their sources.
These markers may refine CV risk stratification in women; leaves open whether they guide therapy or improve outcomes.
AIMS: Global longitudinal strain (GLS) is a strong predictor of adverse cardiovascular outcome in men. However, studies have indicated that GLS may not predict cardiovascular outcomes as effectively in women. The aim of this study was to identify echocardiographic predictors of cardiovascular morbidity and mortality in women from the general population. METHODS AND RESULTS: A total of 1245 women from the general population free of heart failure (HF) and atrial fibrillation had an echocardiographic examination performed including tissue Doppler imaging. In this subset, 747 women had images eligible for strain analysis. Endpoint was a composite of acute myocardial infarction, HF, and cardiovascular death. During follow-up (median 12.5 years), 162 women (13.0%) reached the composite outcome. These women had higher left ventricular (LV) mass index (LVMI), more LV hypertrophy, lower E/A, higher E/e', larger LV dimensions, and longer deceleration time. LVMI and e' remained as significant predictors of the composite outcome [LVMI: hazard ratio (HR) 1.10, 95% confidence interval (CI) 1.03-1.17, P = 0.004, per 5 g/m2 increase] (e': HR 1.53, 95% CI 1.07-2.20, P = 0.020, per 1 cm/s decrease) after adjusting for age, hypertension, systolic blood pressure, diabetes mellitus, total cholesterol, smoking status, prevalent ischaemic heart disease, LV ejection fraction, E/e', E, E/A, interventricular septum thickness in diastole, left ventricular posterior wall in diastole, a', body surface area, and pro-brain natriuretic peptide. GLS was not an independent predictor of outcome after multivariable adjustment. CONCLUSION: The degree of LV hypertrophy assessed as LVMI and diastolic dysfunction evaluated by e' are associated with adverse cardiovascular outcome in women from the general population.
No takes yet. Share an insight, caveat, or question.
Lundorff et al. (2020) conducted a cohort in general population (n=1,245). Left ventricular mass index (LVMI) and e' was evaluated on composite of acute myocardial infarction, HF, and cardiovascular death (HR 1.10, 95% CI 1.03-1.17, p=0.004). Higher left ventricular mass index and lower e' independently predicted acute MI, heart failure, or cardiovascular death in women.
Synapse has enriched 10 related papers. Consider them for comparative context: